Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    0(0%)
    Results Posted
    100%(1 trials)

    Phase Distribution

    Not Applicable
    1
    50%
    Phase 2
    1
    50%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    Phase 2Efficacy & side effects
    1(50.0%)
    N/ANon-phased studies
    1(50.0%)

    Highest Phase Reached

    Phase 2

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    0

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Completed(1)
    Other(1)

    Detailed Status

    Completed1
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    0
    Success Rate
    100.0%
    Most Advanced
    Phase 2

    Trials by Phase

    Phase 21 (50.0%)
    N/A1 (50.0%)

    Trials by Status

    completed150%
    unknown150%

    Recent Activity

    0 active trials
    Showing 2 of 2
    completedphase_2

    Restasis for Treatment of Brittle Nails

    NCT00986427
    unknownnot_applicable

    Efficacy of the Chronic Application of Tear Formulations

    NCT01384851

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT00986427Phase 2

    Restasis for Treatment of Brittle Nails

    Completed
    NCT01384851Not Applicable

    Efficacy of the Chronic Application of Tear Formulations

    Unknown

    All 2 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    2